Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.78
Delayed Data
As of Jun 27
 -0.13 / -6.81%
Today’s Change
1.37
Today|||52-Week Range
2.65
-17.97%
Year-to-Date

Today’s Trading

Previous close1.91
Today’s open1.92
Day’s range1.73 - 1.92
Volume228,508
Average volume (3 months)135,739
Market cap$135.7M
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-54.55%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book4.12

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...-0.57-5.38%
CLSDClearside Biomedical...+0.20+2.94%
STMLStemline Therapeutic...-0.44-6.29%
ECYTEndocyte Inc-0.22-6.69%
Data as of 06/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers

Search for Jobs